Jacob A. Orville - 05 Aug 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role: EVP, GM, Screening
Signature: /s/ Jacob A. Orville by Mark Busch, attorney-in-fact
Issuer symbol: EXAS
Transactions as of: 05 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Aug 2024, 17:30:02 UTC
Previous filing: 02 May 2024
Next filing: 21 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EXAS	Common Stock						14,440	05 Aug 2024	Direct	F1
holding	EXAS	Common Stock						1,117	05 Aug 2024	Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EXAS	Restricted Stock Units	Award	$0	+21,401		$0.000000	21,401	05 Aug 2024	Common Stock	21,401		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In addition to the shares of Common Stock reported on this Form 4, which total 15,557 shares, Mr. Orville also holds, in the aggregate, an additional 72,107 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	These restricted stock units vest in four equal annual installments beginning on August 5, 2025.